Sowell Financial Services’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.2M Sell
44,316
-497
-1% -$107K 0.36% 50
2026
Q1
$9.75M Sell
44,813
-2,651
-6% -$588K 0.36% 51
2025
Q4
$10.8M Sell
47,464
-5,761
-11% -$1.31M 0.4% 45
2025
Q3
$12.3M Sell
53,225
-8,716
-14% -$1.77M 0.47% 38
2025
Q2
$11.5M Sell
61,941
-1,610
-3% -$299K 0.47% 38
2025
Q1
$13.3M Buy
63,551
+4,979
+9% +$968K 0.61% 26
2024
Q4
$10.4M Buy
58,572
+746
+1% +$137K 0.55% 36
2024
Q3
$11.4M Sell
57,826
-3,959
-6% -$739K 0.53% 38
2024
Q2
$10.6M Buy
61,785
+2,500
+4% +$414K 0.51% 42
2024
Q1
$10.8M Sell
59,285
-498
-0.8% -$85.8K 0.51% 40
2023
Q4
$9.27M Sell
59,783
-1,510
-2% -$220K 0.5% 44
2023
Q3
$9.14M Buy
61,293
+2,498
+4% +$367K 0.57% 33
2023
Q2
$7.92M Buy
58,795
+16,027
+37% +$2.35M 0.44% 49
2023
Q1
$6.82M Sell
42,768
-15,438
-27% -$2.36M 0.53% 34
2022
Q4
$9.41M Buy
58,206
+15,067
+35% +$2.31M 0.61% 28
2022
Q3
$5.79M Sell
43,139
-1,540
-3% -$221K 0.58% 33
2022
Q2
$6.84M Buy
44,679
+26,537
+146% +$4.05M 0.63% 30
2022
Q1
$2.92M Sell
18,142
-22,167
-55% -$3.22M 0.51% 39
2021
Q4
$5.46M Sell
40,309
-11,540
-22% -$1.36M 0.31% 69
2021
Q3
$5.59M Sell
51,849
-35,907
-41% -$4.1M 0.38% 61
2021
Q2
$9.88M Sell
87,756
-12,031
-12% -$1.35M 0.65% 29
2021
Q1
$11.6M Buy
99,787
+11,029
+12% +$1.18M 0.4% 54
2020
Q4
$9.51M Buy
88,758
+2,207
+3% +$212K 0.41% 55
2020
Q3
$7.58M Buy
86,551
+7,923
+10% +$746K 0.38% 62
2020
Q2
$7.72M Buy
78,628
+21,662
+38% +$1.91M 0.42% 59
2020
Q1
$4.34M Buy
56,966
+4,270
+8% +$364K 0.32% 81
2019
Q4
$4.67M Sell
52,696
-797
-1% -$66.2K 0.36% 57
2019
Q3
$4.05M Buy
+53,493
New +$3.67M 0.33% 65
2019
Q1
$3.68M Buy
45,688
+1,932
+4% +$158K 0.41% 51
2018
Q4
$4.03M Buy
43,756
+3,464
+9% +$305K 0.57% 40
2018
Q3
$3.81M Buy
40,292
+1,434
+4% +$136K 0.55% 41
2018
Q2
$3.76M Buy
38,858
+1,563
+4% +$153K 0.8% 33
2018
Q1
$3.74M Sell
37,295
-9,727
-21% -$1.07M 0.94% 27
2017
Q4
$4.88M Sell
47,022
-3,373
-7% -$318K 1.19% 20
2017
Q3
$4.66M Sell
50,395
-2,934
-6% -$223K 1.21% 23
2017
Q2
$3.81M Sell
53,329
-1,364
-2% -$91.7K 1.08% 26
2017
Q1
$3.61M Buy
54,693
+1,151
+2% +$72.4K 1.06% 25
2016
Q4
$3.26M Buy
+53,542
New +$3.27M 1.09% 24

Other funds holding ABBV

Sowell Financial Services's ABBV Position: Q2 2026 in Review

Sowell Financial Services reduced its AbbVie (ABBV) stake by 1.1% in Q2 2026, selling an estimated $107K and leaving 44,316 shares worth $11.2M. The position accounts for 0.36% of the portfolio, ranked #50.

Sowell Financial Services first reported a position in ABBV in Q4 2016 and has held it in 38 quarters since. The position peaked at $13.3M in Q1 2025. 4,208 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Sowell Financial Services held 44,316 shares of AbbVie worth $11.2M as of Q2 2026.
  • Sowell Financial Services sold 497 AbbVie shares in Q2 2026, an estimated $107K.
  • AbbVie made up 0.36% of Sowell Financial Services's portfolio in Q2 2026, its #50 holding.
  • Sowell Financial Services first reported a position in AbbVie in Q4 2016 and has held it in 38 quarters since.
  • Sowell Financial Services's AbbVie position peaked at $13.3M in Q1 2025.
  • 4,208 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Sowell Financial Services's 13F filing for Q2 2026, filed 20 Jul 2026.